21 – 30 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Monotherapy with infusion therapies – useful or not?
- Contribution to journal › Scientific review
-
Mark
Economic Burden of Parkinson’s Disease : A Multinational, Real-World, Cost-of-Illness Study
- Contribution to journal › Article
-
Mark
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
- Contribution to journal › Article
-
Mark
Factors associated with self-rated health in people with late-stage parkinson’s and cognitive impairment
- Contribution to journal › Article
-
Mark
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
- Contribution to journal › Article
-
Mark
Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology
- Contribution to journal › Article
-
Mark
The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson’s Disease
- Contribution to journal › Article
-
Mark
Care of Late-Stage Parkinsonism : Resource Utilization of the Disease in Five European Countries
- Contribution to journal › Article
- 2023
-
Mark
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum : Revelations from the MANAGE-PD validation cohort
- Contribution to journal › Article
-
Mark
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease : clinical and therapeutic considerations
- Contribution to journal › Scientific review
